0
0
0
A bill to facilitate the development of treatments for cancers, and for other purposes.
2/27/2025, 11:56 AM
Summary of Bill S 755
Bill 119 s 755, also known as the "Cancer Treatment Facilitation Act," aims to streamline the process for developing new treatments for various types of cancer. The bill includes provisions to improve coordination between government agencies, research institutions, and pharmaceutical companies in order to expedite the research and development of innovative cancer therapies.
One key aspect of the bill is the establishment of a task force dedicated to identifying barriers to cancer treatment development and recommending solutions to overcome these obstacles. This task force will be composed of experts from the fields of oncology, pharmacology, and regulatory affairs, among others.
Additionally, the bill includes measures to increase funding for cancer research and clinical trials, with a focus on promoting collaboration between public and private entities. This funding will support the development of new drugs, therapies, and diagnostic tools for cancer patients. Overall, Bill 119 s 755 seeks to enhance the efficiency and effectiveness of the cancer treatment development process, ultimately aiming to improve outcomes for individuals battling cancer. The bill is a bipartisan effort to address the urgent need for innovative treatments in the fight against cancer.
One key aspect of the bill is the establishment of a task force dedicated to identifying barriers to cancer treatment development and recommending solutions to overcome these obstacles. This task force will be composed of experts from the fields of oncology, pharmacology, and regulatory affairs, among others.
Additionally, the bill includes measures to increase funding for cancer research and clinical trials, with a focus on promoting collaboration between public and private entities. This funding will support the development of new drugs, therapies, and diagnostic tools for cancer patients. Overall, Bill 119 s 755 seeks to enhance the efficiency and effectiveness of the cancer treatment development process, ultimately aiming to improve outcomes for individuals battling cancer. The bill is a bipartisan effort to address the urgent need for innovative treatments in the fight against cancer.
Congressional Summary of S 755
Finn Sawyer Access to Cancer Testing Act
This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.
Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.
Current Status of Bill S 755
Bill S 755 is currently in the status of Bill Introduced since February 26, 2025. Bill S 755 was introduced during Congress 119 and was introduced to the Senate on February 26, 2025. Bill S 755's most recent activity was Read twice and referred to the Committee on Finance. as of February 26, 2025
Bipartisan Support of Bill S 755
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
1Democrat Cosponsors
1Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 755
Primary Policy Focus
Alternate Title(s) of Bill S 755
A bill to facilitate the development of treatments for cancers, and for other purposes.
A bill to facilitate the development of treatments for cancers, and for other purposes.
Comments
Sponsors and Cosponsors of S 755
Latest Bills
ELO Realignment and Strategic Engagement Reform Act of 2026
Bill HR 7574February 14, 2026
Farm, Food, and National Security Act of 2026
Bill HR 7567February 14, 2026
Expressing the condolences of the House of Representatives and honoring the memory of the victims of the mass shooting in Aurora, Illinois, on February 15, 2019.
Bill HRES 1066February 14, 2026
Condemning and censuring President Donald Trump.
Bill HRES 1065February 14, 2026
To amend the Internal Revenue Code of 1986 to exclude automobiles from being treated as collectibles for purposes of capital gains tax, and for other purposes.
Bill HR 7582February 14, 2026
To allow Americans to earn paid sick time so that they can address their own health needs and the health needs of their families.
Bill HR 7531February 14, 2026
To address the needs of workers in industries likely to be impacted by rapidly evolving technologies.
Bill HR 7585February 14, 2026
To amend the Food, Conservation, and Energy Act of 2008 with respect to the Gus Schumacher Nutrition Incentive Program and the sustainability of such program, and for other purposes.
Bill HR 7571February 14, 2026
Supporting the goals and ideals of "Career and Technical Education Month".
Bill HRES 1063February 14, 2026
To prevent discrimination, including harassment, in employment.
Bill HR 7583February 14, 2026